Illumina, Inc. (ILMN) - Product Pipeline Analysis, Develop Market-Entry and Market Expansion Strategies, 2015 Update

Albany, NY -- (ReleaseWire) -- 05/05/2015 -- Illumina, Inc. (Illumina) is a molecular diagnostics company. It develops, manufactures and markets life science tools and integrated systems for genetic variation and function analysis. The company offers solutions for copy number variation, single nucleotide polymorphism genotyping, gene expression profiling of DNA and RNA, and deoxyribonucleic acid methylation studies. Illumina offers its services to pharmaceutical companies, genomic research centers, academic institutions, biotechnology companies and clinical research organizations. The products offered by Illumina for genomic analysis include HiSeq 2500, NextSeq 500, MiSeq, HiScanSQ systems. The core technologies of the company include Sequencing by Synthesis (SBS), BeadArray and Real-Time PCR technology. The company's products are distributed to various countries through its distributors in Europe, India, Israel, Korea, Malaysia, Greece, Turkey, Taiwan, Thailand, Vietnam, South Africa, Saudi Arabia, Russia, Ukraine, Belarus and other countries. Illumina is headquartered in San Diego, California, the US.